Both in Biotechnology
ProKidney vs Fate Therapeutics
Over the past year PROK returned −61.6% and FATE returned +64.3%; their daily moves had a correlation of 0.34.
PROK −61.6% FATE +64.3%Growth of $1, one year, split-adjusted
| Metric | PROK | FATE |
|---|---|---|
| Price | $1.10 | $2.07 |
| Market cap | $228.8M | $248.0M |
| Today | +2.34% | +1.47% |
| 1 month | −31.6% | −9.6% |
| 6 months | −44.1% | −9.6% |
| Year to date | −51.1% | +110.7% |
| 1 year | −61.6% | +64.3% |
| Revenue growth (YoY) | −32.1% | +9.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −18948.0% | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | 279.7× | 38.2× |
| Net cash | $181.6M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 85.1% | 56.3% |
| Short % of float | 27.4% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).